GO:0004719 protein-L-isoaspartate (D-aspartate) O-methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004719 describes the enzymatic activity that repairs age-damaged proteins by methylating abnormal L-isoaspartate and D-aspartate residues, using S-adenosyl-L-methionine as the methyl donor.
• The enzyme, often called PIMT or PCMT1, is conserved from bacteria to humans and functions as a protein repair methyltransferase that helps maintain protein integrity during aging and oxidative stress.
• PIMT protects cardiomyocytes from hypoxia-induced apoptosis by inhibiting the proapoptotic kinase Mst1, linking this activity to cell survival under stress.
• Mice lacking PIMT exhibit seizures and increased mortality, demonstrating its critical role in normal brain function and neuronal survival.
• PIMT regulates p53 activity, connecting protein isoaspartate repair to tumor suppressor function and cancer biology.
• The human genome encodes PCMTD1, a PIMT domain-containing protein that associates with Cullin-RING ligase complexes, suggesting broader roles in protein quality control beyond direct repair.
Description
Protein-L-isoaspartate (D-aspartate) O-methyltransferase activity, encoded by GO:0004719, is a molecular function that catalyzes the methylation of abnormal aspartate residues in proteins. This activity is essential for repairing proteins that have undergone spontaneous deamidation or isomerization, processes that accumulate with age and oxidative stress. The enzyme transfers a methyl group from S-adenosyl-L-methionine to the alpha-carboxyl group of L-isoaspartate or D-aspartate residues, initiating a repair pathway that restores protein function. Researchers study this activity because it represents a key defense against protein damage, with implications for aging, neurodegeneration, and cancer.
protein-L-isoaspartate (D-aspartate) O-methyltransferase activity At A Glance
| GO ID | GO:0004719 |
|---|---|
| GO term | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity |
| Ontology | molecular_function |
| Synonym | protein L-isoaspartyl methyltransferase activity; D-aspartyl/L-isoaspartyl methyltransferase activity; protein beta-aspartate O-methyltransferase activity |
| Major function | Repair of age-damaged proteins by methylating L-isoaspartate and D-aspartate residues |
| Reaction | S-adenosyl-L-methionine + protein L-beta-aspartate = S-adenosyl-L-homocysteine + protein L-beta-aspartate methyl ester |
| Cofactor | S-adenosyl-L-methionine (SAM) as methyl donor |
| Subcellular location | Cytoplasm and nucleus (as inferred from gene ontology annotations) |
What Is GO:0004719?
GO:0004719 is defined as the catalysis of the reaction: S-adenosyl-L-methionine + protein L-beta-aspartate = S-adenosyl-L-homocysteine + protein L-beta-aspartate methyl ester. In simpler terms, it is an enzyme activity that uses SAM to methylate damaged aspartate residues in proteins, forming a methyl ester intermediate that can be converted back to a normal aspartate, thereby repairing the protein.
Why Is protein-L-isoaspartate (D-aspartate) O-methyltransferase activity Important in Cell Biology?
This activity is critical for maintaining protein homeostasis and cellular survival under stress. By repairing damaged aspartate residues, PIMT prevents the accumulation of abnormal proteins that can disrupt cellular functions and contribute to aging and disease. Its role in protecting cardiomyocytes from apoptosis and regulating p53 highlights its importance in both cell survival and tumor suppression.
• Repairs age-damaged proteins, counteracting the effects of spontaneous deamidation and isomerization.
• Protects cardiomyocytes from hypoxia-induced apoptosis by inhibiting Mst1 kinase.
• Prevents seizures and neuronal dysfunction in mice, indicating a role in brain health.
• Regulates p53 activity, linking protein repair to cancer pathways.
• Inhibits protein fibrillation, suggesting a protective role against neurodegenerative aggregates.
• Involved in intracellular signal transduction, potentially affecting multiple signaling cascades.
• Human PCMTD1, a PIMT domain-containing protein, interacts with Cullin-RING ligases, implicating it in ubiquitin-mediated processes.
• Polymorphic forms of PIMT in humans may influence individual susceptibility to age-related diseases.
• Provides a model for studying protein repair mechanisms and their impact on aging.
• Potential therapeutic target for conditions characterized by protein damage, such as neurodegeneration and heart disease.
Molecular Mechanism of protein-L-isoaspartate (D-aspartate) O-methyltransferase activity
Substrate Recognition and Binding
In simple terms: The enzyme finds and attaches to damaged proteins.
PIMT specifically recognizes proteins containing L-isoaspartate or D-aspartate residues, which arise from spontaneous deamidation or isomerization of normal L-aspartate. The enzyme binds these abnormal residues with high affinity, positioning them for methylation.
Methyl Transfer from SAM
In simple terms: The enzyme uses SAM to add a methyl group to the damaged site.
Using S-adenosyl-L-methionine (SAM) as the methyl donor, PIMT catalyzes the transfer of a methyl group to the alpha-carboxyl group of the abnormal aspartate, forming a methyl ester intermediate. This reaction produces S-adenosyl-L-homocysteine as a byproduct.
Repair and Restoration
In simple terms: The methyl ester helps convert the damaged residue back to normal.
The methyl ester intermediate is unstable and can spontaneously hydrolyze to form a succinimide, which then hydrolyzes to restore the normal L-aspartate residue, completing the repair. This repair process prevents the accumulation of damaged proteins and maintains protein function.
Regulation and Interacting Partners
In simple terms: Other proteins can influence how well this enzyme works.
PIMT activity can be regulated by interacting proteins; for example, human PCMTD1 associates with Cullin-RING ligase complexes, potentially linking PIMT-related repair to ubiquitin-mediated protein degradation. Additionally, PIMT regulates p53 activity, suggesting a role in signaling pathways.
Role in Stress Response
In simple terms: The enzyme helps cells survive stressful conditions.
Under hypoxia, PIMT protects cardiomyocytes from apoptosis by inhibiting the proapoptotic kinase Mst1. This indicates that PIMT activity is integrated into cellular stress responses and survival signaling.
Key Genes Involved in GO:0004719 protein-L-isoaspartate (D-aspartate) O-methyltransferase activity
The following genes and proteins are directly involved in or regulate protein-L-isoaspartate (D-aspartate) O-methyltransferase activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PCMT1 | Encodes the main protein-L-isoaspartate (D-aspartate) O-methyltransferase enzyme | Central to protein repair; knockout mice show seizures |
| PCMTD1 | PIMT domain-containing protein 1; associates with Cullin-RING ligases | Links PIMT activity to ubiquitin-mediated processes |
| MST1 | Proapoptotic kinase inhibited by PIMT | Mediates PIMT's protective effect in cardiomyocytes |
| TP53 | Tumor suppressor regulated by PIMT | Connects protein repair to cancer pathways |
| HPRT | Hypoxanthine phosphoribosyltransferase; model substrate for PIMT | Used to study repair of deamidated proteins |
| CRL | Cullin-RING ligase complexes interacting with PCMTD1 | Implicated in protein quality control |
| SAM | S-adenosyl-L-methionine; methyl donor | Essential cofactor for the methylation reaction |
| SAH | S-adenosyl-L-homocysteine; byproduct | Product of the reaction |
| L-isoaspartate | Abnormal aspartate residue in proteins | Substrate for PIMT |
| D-aspartate | Abnormal aspartate stereoisomer | Substrate for PIMT |
| Succinimide | Intermediate in repair pathway | Key to restoring normal aspartate |
| p53 | Tumor suppressor protein | Regulated by PIMT |
| Mst1 | Kinase involved in apoptosis | Inhibited by PIMT |
| PIMT | Protein-L-isoaspartate O-methyltransferase enzyme | The enzyme itself; conserved from bacteria to humans |
| PCMT1 polymorphic variants | Naturally occurring variants in humans | May affect repair efficiency and disease susceptibility |
How Is protein-L-isoaspartate (D-aspartate) O-methyltransferase activity Regulated?
PIMT activity is regulated at multiple levels. Its expression can be induced under stress conditions, and its activity can be modulated by interacting proteins such as PCMTD1, which links it to Cullin-RING ligases. Additionally, PIMT regulates p53 activity, suggesting a feedback loop in signaling pathways. In cardiomyocytes, PIMT protects against hypoxia-induced apoptosis by inhibiting Mst1, indicating that its function is integrated into stress-responsive signaling networks.
protein-L-isoaspartate (D-aspartate) O-methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PCMT1 | Seizures and neurodegeneration | Pcmt1 knockout mouse |
| PCMT1 | Cardiomyocyte apoptosis under hypoxia | Hypoxia-treated cardiomyocytes with PIMT overexpression |
| PCMT1 | Cancer via p53 regulation | Cancer cell lines with PIMT knockdown |
| PCMT1 | Protein fibrillation | In vitro fibrillation assays with PIMT |
| PCMTD1 | Protein quality control | Cells with PCMTD1 knockout |
Neurodegeneration and Seizures
Mice lacking PIMT exhibit seizures and increased mortality, demonstrating that this activity is essential for normal brain function. The accumulation of damaged proteins in the brain may contribute to neuronal hyperexcitability and neurodegeneration.
Cardiovascular Disease
PIMT protects cardiomyocytes against hypoxia-induced apoptosis by inhibiting the proapoptotic kinase Mst1. This suggests that reduced PIMT activity could exacerbate ischemic heart damage and that enhancing its activity might be cardioprotective.
Cancer
PIMT regulates p53 activity, linking protein isoaspartate repair to tumor suppression. Dysregulation of PIMT could therefore impact cancer development and progression.
Protein Fibrillation and Aggregation
PIMT prevents protein fibrillation, suggesting a protective role against neurodegenerative diseases characterized by protein aggregates. This positions PIMT as a potential therapeutic target for amyloid-related disorders.
From protein-L-isoaspartate (D-aspartate) O-methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of PIMT loss on neuronal function? | Pcmt1 knockout mouse |
| Does PIMT protect cardiomyocytes from hypoxia? | Cardiomyocyte-specific PIMT overexpression |
| How does PIMT regulate p53? | PIMT knockout cancer cell lines |
| Does PIMT prevent protein fibrillation? | In vitro fibrillation assays with recombinant PIMT |
| What is the role of PCMTD1 in protein repair? | PCMTD1 knockout cells |
| How do human PIMT polymorphisms affect activity? | Knock-in mice expressing human variants |
How to Study the protein-L-isoaspartate (D-aspartate) O-methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioactive methylation assay | PIMT enzymatic activity | Quantifying repair capacity in cell lysates |
| Mass spectrometry | Isoaspartate levels in proteins | Detecting age-related protein damage |
| Western blot | Protein expression and phosphorylation | Assessing PIMT and p53 levels |
| Co-immunoprecipitation | Protein-protein interactions | Identifying PIMT binding partners |
| CRISPR knockout | Loss-of-function phenotypes | Studying PIMT role in cells and mice |
| Fibrillation assays | Protein aggregation kinetics | Testing PIMT's anti-fibrillation activity |
| Apoptosis assays | Cell survival | Evaluating PIMT protection under hypoxia |
| Seizure monitoring | Neurological phenotype | Assessing PIMT knockout mice |
Enzymatic Activity Assays
PIMT activity can be measured using radioactive SAM or fluorescent substrates to quantify methyl transfer to isoaspartate-containing peptides.
Proteomic Detection of Isoaspartate
Isoaspartate residues can be detected by mass spectrometry or specific antibodies to assess the accumulation of damaged proteins in cells or tissues.
Genetic Knockout and Knockdown
CRISPR-Cas9 or RNAi can be used to deplete PIMT in cell lines or model organisms to study its loss-of-function phenotypes.
Protein Interaction Studies
Co-immunoprecipitation and mass spectrometry can identify interacting partners such as PCMTD1 and Mst1.
How CRISPR Can Be Used to Study GO:0004719 protein-L-isoaspartate (D-aspartate) O-methyltransferase activity
Knockout
CRISPR-Cas9 knockout of PCMT1 can be used to create cell lines or mouse models lacking PIMT activity, enabling studies of protein damage accumulation and associated phenotypes such as seizures.
Point Mutation
Introducing point mutations in the catalytic domain of PCMT1 can help dissect the enzymatic mechanism and identify residues critical for substrate binding or catalysis.
Knock-in
Knock-in of human polymorphic variants of PCMT1 into model organisms can reveal how naturally occurring mutations affect repair efficiency and disease susceptibility.
Overexpression
Overexpression of PCMT1 using CRISPR activation or lentiviral vectors can test whether increased PIMT activity protects against hypoxia-induced apoptosis or protein aggregation.
How EDITGENE Supports protein-L-isoaspartate (D-aspartate) O-methyltransferase activity Research
Researchers studying protein-L-isoaspartate (D-aspartate) O-methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in protein repair, stress responses, or disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for protein-L-isoaspartate (D-aspartate) O-methyltransferase activity research.
Frequently Asked Questions About protein-L-isoaspartate (D-aspartate) O-methyltransferase activity
What is protein-L-isoaspartate (D-aspartate) O-methyltransferase activity?
It is an enzyme activity that repairs damaged aspartate residues in proteins by methylating them using SAM, as defined by GO:0004719.
What genes are involved in protein-L-isoaspartate (D-aspartate) O-methyltransferase activity?
The main gene is PCMT1, which encodes the enzyme; PCMTD1 encodes a related protein, and interacting partners include MST1 and TP53.
What diseases are associated with PIMT deficiency?
PIMT deficiency in mice causes seizures and neurodegeneration; in humans, it may contribute to age-related protein damage and cardiovascular disease.
How does PIMT repair proteins?
PIMT methylates L-isoaspartate or D-aspartate residues, forming a methyl ester that converts back to normal aspartate through a succinimide intermediate.
What is the role of PIMT in cancer?
PIMT regulates p53 activity, suggesting it may influence tumor suppression and cancer progression.
Can CRISPR be used to study PIMT function?
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools to dissect PIMT's role in cells and organisms.
What is the substrate of PIMT?
The substrates are proteins containing abnormal L-isoaspartate or D-aspartate residues, which arise from spontaneous deamidation.
How is PIMT activity measured?
It can be measured using radioactive methylation assays or by detecting isoaspartate levels via mass spectrometry.
Is PIMT conserved across species?
Yes, PIMT is conserved from bacteria to humans, highlighting its fundamental role in protein repair.
What are the symptoms of PIMT knockout in mice?
PIMT knockout mice exhibit seizures, increased mortality, and signs of neurodegeneration.
Conclusion
Protein-L-isoaspartate (D-aspartate) O-methyltransferase activity (GO:0004719) is a vital protein repair mechanism that counteracts age-related damage. Its roles in neuronal survival, cardioprotection, and cancer regulation make it a compelling target for further research. Understanding its mechanism and regulation could lead to new therapeutic strategies for diseases associated with protein damage.
References
- 1. Warmack RA et al.. 2022. Human Protein-l-isoaspartate O-Methyltransferase Domain-Containing Protein 1 (PCMTD1) Associates with Cullin-RING Ligase Proteins.. Biochemistry 61(10):879-894 PMID: 35486881
- 2. DeVry CG et al.. 1999. Polymorphic forms of the protein L-isoaspartate (D-aspartate) O-methyltransferase involved in the repair of age-damaged proteins.. J Hum Genet 44(5):275-88 PMID: 10496068
- 3. Furuchi T et al.. 2010. The role of protein L-isoaspartyl/D-aspartyl O-methyltransferase (PIMT) in intracellular signal transduction.. Chem Biodivers 7(6):1337-48 PMID: 20564550
- 4. Yan G et al.. 2013. Protein-L-isoaspartate (D-aspartate) O-methyltransferase protects cardiomyocytes against hypoxia induced apoptosis through inhibiting proapoptotic kinase Mst1.. Int J Cardiol 168(4):3291-9 PMID: 23647599
- 5. Kim E et al.. 1999. Phenotypic analysis of seizure-prone mice lacking L-isoaspartate (D-aspartate) O-methyltransferase.. J Biol Chem 274(29):20671-8 PMID: 10400700
- 6. Brennan TV et al.. 1994. Repair of spontaneously deamidated HPr phosphocarrier protein catalyzed by the L-isoaspartate-(D-aspartate) O-methyltransferase.. J Biol Chem 269(40):24586-95 PMID: 7929130
- 7. Chatterjee T et al.. 2020. The role of isoaspartate in fibrillation and its prevention by Protein-L-isoaspartyl methyltransferase.. Biochim Biophys Acta Gen Subj 1864(3):129500 PMID: 31785325
- 8. Lee JC et al.. 2012. Protein L-isoaspartyl methyltransferase regulates p53 activity.. Nat Commun 3:927 PMID: 22735455
